Ansbro É, Masri S, Prieto-Merino D, Willis R, Aoun Bahous S, et al.
2023-01-25 • BMJ Open
2023-01-25 • BMJ Open
OBJECTIVES This pre–post implementation study evaluated the introduction of fixed dose combination (FDC) medications for atherosclerotic cardiovascular disease (ASCVD) secondary prev...
Oza S, Harris P, Ansbro E, Perel P, Frieden M, et al.
2020-05-20 • MSF Scientific Days International 2020
2020-05-20 • MSF Scientific Days International 2020
INTRODUCTION Globally, hypertension is responsible for approximately half of all heart disease and stroke deaths. Over 75% of these deaths occur in low- and middle-income countries. ...
Murphy A, Biringanine M, Roberts B, Stringer B, Perel P, et al.
2017-06-23 • BMC Health Services Research
2017-06-23 • BMC Health Services Research
Evidence is urgently needed from complex emergency settings to support efforts to respond to the increasing burden of diabetes mellitus (DM). We conducted a qualitative study of a new mo...
Boulle P, Sibourd Baudry A, Ansbro É, Prieto Merino D, Saleh N, et al.
2019-08-09 • Conflict and Health
2019-08-09 • Conflict and Health
We included 514 patients with ASCVD in the cross-sectional study, performed in 2017. Most (61.9%) were male and mean age was 60.4 years (95% CI, 59.6-61.3). Over half (58.8%) underwent r...
Webster R, Murphy A, Bygrave H, Ansbro É, Grobbee DE, et al.
2019-12-31 • Global Heart
2019-12-31 • Global Heart
HIGHLIGHTS -- Despite clinical evidence of its effectiveness in secondary prevention of cardiovascular disease, uptake of fixed dose combination therapy (FDCs) for CVD has been poor....
Ansbro E, Masri S, Prieto-Merino D, Bahous SA, Molfino L, et al.
2022-05-11 • MSF Scientific Days International 2022
2022-05-11 • MSF Scientific Days International 2022
INTRODUCTION Cardiovascular disease (CVD) is the leading cause of death and disability globally, including in humanitarian contexts. Fixed-dose combination (FDC) drugs are cost-effec...
Kehlenbrink S, Smith JS, Ansbro É, Fuhr D, Cheung ATL, et al.
2019-03-13 • Lancet Diabetes and Endocrinology
2019-03-13 • Lancet Diabetes and Endocrinology
Human suffering as a result of natural disasters or conflict includes death and disability from non-communicable diseases, including diabetes, which have largely been neglected in humani...
Ansbro É, Homan T, Jobanputra K, Qasem J, Muhammad S, et al.
2021-01-11 • PLOS Medicine
2021-01-11 • PLOS Medicine
BACKGROUND Little is known about the content or quality of non-communicable disease (NCD) care in humanitarian settings. Since 2014, Médecins Sans Frontières (MSF) has provided prima...
Vetter B, Beran D, Boulle P, Chua AC, de la Tour R, et al.
2021-10-09 • BMC Cardiovascular Disorders
2021-10-09 • BMC Cardiovascular Disorders
INTRODUCTION Multi-parameter diagnostic devices can simplify cardiometabolic disease diagnosis. However, existing devices may not be suitable for use in low-resource settings, where ...
Ansbro É, Homan T, Qasem J, Bil K, Tarawneh M, et al.
2021-04-26 • BMC Health Services Research
2021-04-26 • BMC Health Services Research
BACKGROUND In response to the rising global NCD burden, humanitarian actors have rapidly scaled-up NCD services in crisis-affected low-and-middle income countries. Using the RE-AIM i...
Murphy A, Willis R, Ansbro É, Masri S, Kabbara N, et al.
2022-06-04 • BMC Health Services Research
2022-06-04 • BMC Health Services Research
BACKGROUND We report findings of a qualitative evaluation of fixed-dose combination therapy for patients with established atherosclerotic cardiovascular disease (ASCVD) attending Méd...
